Ep135: John Maraganore on Developing a New Class of Medicines
John Maraganore, former founding CEO of Alnylam P…
An episode of the The Long Run with Luke Timmerman podcast, hosted by Timmerman Report, titled "Ep135: John Maraganore on Developing a New Class of Medicines" was published on May 8, 2023 and runs 63 minutes.
May 8, 2023 ·63m · The Long Run with Luke Timmerman
Summary
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.
Episode Description
Similar Episodes
Apr 13, 2026 ·46m
Apr 8, 2026 ·19m
Apr 6, 2026 ·48m